Citations

Mayo Clinic

Clear

1586 citation(s) found for "Qi, Wei".

Faculty Opinions recommendation of Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia.
Meng, Wei , Kaufmann, Scott H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726465378.793525471 Get It

Faculty Opinions recommendation of Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Meng, Wei , Kaufmann, Scott H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726356653.793525469 Get It

Faculty Opinions recommendation of The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism.
Meng, Wei , Kaufmann, Scott H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726281749.793525470 Get It

Faculty Opinions recommendation of Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 study.
Meng, Wei , Kaufmann, Scott H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726978664.793525467 Get It

Faculty Opinions recommendation of A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors.
Meng, Wei , Kaufmann, Scott H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726978662.793525466 Get It

Faculty Opinions recommendation of Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.
Meng, Wei , Kaufmann, Scott H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725994198.793525468 Get It

Faculty Opinions recommendation of A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia.
Meng, Wei , Kaufmann, Scott H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725400916.793525465 Get It

Late outcomes of adult survivors of childhood non‐Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study
Ehrhardt, Matthew J. , Sandlund, John T., Zhang, Nan , Liu, Wei , Ness, Kirsten K. , Bhakta, Nickhill , Chemaitilly, Wassim , Krull, Kevin R. , Brinkman, Tara M. , Crom, Deborah B., Kun, Larry E. , Kaste, Sue C. , Armstrong, Gregory T. , Srivastava, Kumar , Mulrooney, Daniel A. , Green, Daniel M. , Robison, Leslie L. , Hudson, Melissa M. , Mulrooney, Daniel A , Ness, Kirsten K , Bhakta, Nickhill

Pediatric Blood & Cancer | November 16, 2016 | Volume: 64 | Issue: 6 | Pages: No page available

10.1002/pbc.26338 | PMID 27860222 Get It

AbstractBackgroundSurvivors of childhood non‐Hodgkin lymphoma (NHL) are at increased risk for chronic health conditions. The objective of this study was to characterize health conditions, neurocognitive function, and physical performance among a clinically evaluated cohort of 200 childhood NHL survivors.MethodChronic health and neurocognitive conditions were graded as per a modified version of the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) and impaired physical function defined as performance < 10th percentile of normative data. Multivariable regression was used to investigate associations between sociodemographic characteristics, therapeutic exposures, and outcomes.ResultsSurvivors were a median age of 10 years (range 1–19) at diagnosis and 34 years (range 20–58) at evaluation. Eighty‐eight (44%) received radiation, 46 (23%) cranial radiation, and 69 (35%) high‐dose methotrexate. Most prevalent CTCAE Grades 3–4 (severe life‐threatening) conditions were obesity (35%), hypertension (9%), and impairment of executive function (13%), attention (9%), and memory (4%). Many had impaired strength (48%), flexibility (39%), muscular endurance (36%), and mobility (36%). Demographic and treatment‐related factors were associated with the development of individual chronic diseases and functional deficits.ConclusionsClinical evaluation identified a high prevalence of chronic health conditions, neurocognitive deficits, and performance limitations in childhood NHL survivors.
Xanthogranuloma of the sellar region diagnosed by frozen section
Ji, Kun , Zhang, Liyan , Wang, Liwei , Wang, Wei , Wang, Liwei, Wang, Wei

Open Medicine | November 10, 2016 | Volume: 11 | Issue: 1 | Pages: 426-428

10.1515/med-2016-0076 | PMID 28352831 Get It

Abstract Xanthogranuloma (XG) of the sellar region is uncommon and is difficult to diagnose based on intraoperative frozen sections. This study is a case presentation and review of the literature, highlighting the need to explore underlying diseases in order to guarantee an accurate patient diagnosis. Herein, we presented the case of a 43-year-old woman who was afflicted with xanthogranuloma of the sellar region; the patient had a history of headache and lengthened menstrual cycles over the 6 months prior to presentation. Endocrinology tests revealed that the patient’s levels of prolactin were high and the MRI of the patient showed a clearly defined sellar mass. As a result, the patient was considered to have prolactinoma prior to undergoing surgery. The tumor was completely removed using a transsphenoidal approach, and intraoperative frozen section revealed histology similar to xanthogranuloma. When the tumor was removed by surgical operation, the patient’s visual field defects and headache were relieved. Although intraoperative frozen section should provide some guidance with regard to the diagnosis, a pathological study is conducted to confirm the actual diagnosis.